期刊文献+

多发性硬化的磁共振波谱研究 被引量:15

Study of 1^H magnetic resonance spectroscopy in multiple sclerosis
下载PDF
导出
摘要 目的研究多发性硬化(MS)患者脑内病灶、表现正常脑白质(NAWM)及正常志愿者脑白质的代谢差异,并探讨代谢物浓度比值与临床残疾程度的相关性。方法对32例MS患者和25例正常志愿者进行MRI和质子磁共振波谱(1H MRS)检查,测量各感兴趣区的代谢产物氮-乙酰天冬氨酸(NAA)、肌酸(Cr)及胆碱(Cho)的浓度比率,并分析NAA/Cr及NAA/Cho与扩展残疾状态量表(EDSS)的相关性。结果MS患者的病灶内NAA/Cr及NAA/Cho显著低于NAWM(P<0.001),NAWM的NAA/Cr及NAA/Cho亦显著低于正常对照组(P<0.001)。MS患者病灶和NAWM的NAA/Cr及NAA/Cho与EDSS均无显著相关性。结论1H MRS能检测出MS患者脑部病灶及NAWM的代谢异常,为常规MRI提供补充信息。 Objective To study the difference of metabolic characteristics among lesions, normal-appearing white matter (NAWM) in multiple sclerosis (MS) and white matter in normal volunteers, and to investigate correlation between ratios of metabolite concentration and clinical disability. Methods MRI and ^1H magnetic resonance spectroscopy (^1H MRS) were performed in 32 MS patients and 25 healthy volunteers. The ratios of N-acetylaspartate (NAA), creatine (Cr) and choline (Cho) peaks were measured in each volume of interest, and the correlation of expanded disability status scale (EDSS) with NAA/Cr and NAA/Cho were analyzed. Results NAA/Cr and NAA/Cho of lesions were significantly lower than those of NAWM in MS patients (P〈0. 001). NAA/Cr and NAA/Cho of NAWM in MS were also significantly lower than those of normal white matter in control subjects (P〈0. 001). No significant correlation was found between EDSS and NAA/Cr or NAA/Cho in both MS lesions and NAWM. Conclusion ^1H MRS can detect metabolic abnormalities in brain lesions and NAWM from MS patients and provide complementary information for conventional MRI.
出处 《中国医学影像技术》 CSCD 北大核心 2006年第1期67-69,共3页 Chinese Journal of Medical Imaging Technology
基金 北京市优秀人才培养专项经费资助(20041D0501825)。
关键词 多发性硬化 质子磁共振波谱 磁共振成像 Multiple sclerosist ^1 H magnetic resonance spectroscopy, Magnetic resonance imaging
  • 相关文献

参考文献2

二级参考文献20

  • 1李小明,史瑞华,李勇刚,胡军武,张景峰,徐安辉,张伶.MR弥散张量成像在中枢神经系统的临床应用[J].中国医学影像技术,2004,20(10):1627-1631. 被引量:9
  • 2Wang Z,Zimmerman RA,Sauter R.Proton MR spectroscopy of the brain clinically useful information obtained in assessing CNS diseases in children[J].AJR,1996,167:19-199.
  • 3Fanklyn A,Kirstie H,Opstad S.^1H MR spectroscopy of brain tumors and masses[J].NMR Biomed,2003;16:123-131.
  • 4Connelly A,van Pawsschen W,Poter DA,et al.Proton magnetic resonance spectrocopy in MRI-negative lobe epilepsy[J].Neurology,1998,51:61.
  • 5Vikhoff-Baaz B,Malmgren K,Jonsson L,et al.Lateralisation with magnetic resonance spectroscopic imaging in temporal lobe epilepsy:an evaluation of visual and region of interest analysis of metabolite concentration images[J].Neuroadiology,2001,43:721.
  • 6Michael JF,Fracp AB,Mark JD,et al Mapping of brain tumor metabolites with proton MR spectroscopic imaging:clinical relevanece[J].Radiology,1992,185:675-686.
  • 7Breiter SN,Arroyo S,Mathews VP,et al.Pronton MR spectroscopy in patients with seizure disorders[J].AJNR,1994,15:373.
  • 8Connelly A,Jackson GD,Duncan JS,et al.Magnetic resonance spectroscopy in temporal lobe epilepsy[J].Neurology,1994,44:1441.
  • 9Ende GR,Laxer KD,Knowlton RC,et al.Temporal lobe epiepsy:bilateral hippocampal metabolite changes revaled at proton MR spectroscopic imaging[J].Radiology,1997,202:809.
  • 10Clarke CE,Lowry M.Systematic review of proton magnetic resonance spectroscopy of the striatum in Parkinsonian syndromes[J].Eur J Neurol,2001,8(6):573-577.

共引文献13

同被引文献136

引证文献15

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部